Last checked at 13 Nov 2014 10:02
For immediate release | 13 November 2014 |
Futura Medical plc
("Futura" or the "Company")
Directorate Change
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that David Davies has decided to leave the Company to pursue new opportunities. Mr Davies' departure from the Company will take place during the first half of next year after the transition of his responsibilities to Futura's recently strengthened product development team. The effective date of his ceasing to be a Director of the Company will be confirmed in due course.
James Barder, Futura's Chief Executive, said: "David has been with Futura for a total of 13 years, during which time the Company has evolved considerably. I would like to thank David for his contribution to Futura and wish him well for the future."
For further information:
Futura Medical plc | + 44 (0) 1483 685 670 |
James Barder, Chief Executive Officer | |
Mail to: James.Barder@futuramedical.com | www.futuramedical.com |
N+1 Singer (Nominated Adviser and Broker) | + 44 (0) 20 7496 3000 |
Aubrey Powell - Corporate Finance Brough Ransom - Sales | |
Buchanan |
+ 44 (0) 20 7466 5000 |
Mark Court / Sophie Cowles |
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups. Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com